NICE recommends semaglutide for obesity treatmentThousands of people living with obesity are set to benefit from a new drug which has helped those using it to reduce their weight by more...
nanoMesh files second PMA (510(k)) with FDA for Exogenesis Hernia MeshnanoMesh, a subsidiary of Exogenesis, has successfully completed filing of a second Pre-Marketing Notification Application (510(k)) with...
GLP-1s associated with higher risk of major depression, increased risk for anxiety and an elevated risk for suicidal behaviour19 hours ago